For MAD2L1 84Leu/Met genotype, smokers carrying Met-containing genotypes were observed to confer a 2.63-fold increased risk of CRC compared with nonsmokers with wide genotypes (95% CI: 1.71–4.05). This evidence concerns the gene MAD2L1 and colorectal carcinoma.